Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nomifensine: clinical data (author's transl)].

G Clerc, M Cayreyre

    La Nouvelle Presse Medicale
    |June 28, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Nomifensine demonstrated effectiveness in treating neurotic and reactive depressions by counteracting inhibition and restoring drive. This antidepressant showed no significant cardiovascular or anticholinergic side-effects and did not potentiate alcohol effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thymic localization of erythrodermic cutaneous T-cell lymphoma.

    The British journal of dermatology·2018
    Same author

    Atherosclerosis in developing and developed countries: relation with immune dysregulation and hygiene hypothesis.

    Medical hypotheses·2005
    Same author

    Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.

    The American journal of psychiatry·2002
    Same author

    Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.

    International clinical psychopharmacology·2001
    Same author

    Lymphocyte subsets in severe atherosclerosis before revascularization.

    Annals of internal medicine·1997
    Same author

    Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice.

    International clinical psychopharmacology·1996
    Same journal

    [Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

    La Nouvelle presse medicale·2016
    Same journal

    [Cutaneous systemic angiitis in hairy cell leukemia].

    La Nouvelle presse medicale·1982
    Same journal

    [Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

    La Nouvelle presse medicale·1982
    Same journal

    [Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

    La Nouvelle presse medicale·1982
    Same journal

    [Relation between psychological stress and obstetrical complications. Preliminary data].

    La Nouvelle presse medicale·1982
    Same journal

    [Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

    La Nouvelle presse medicale·1982
    See all related articles

    Area of Science:

    • Psychiatry
    • Pharmacology
    • Clinical Trials

    Background:

    • Depression is a significant mental health condition requiring effective pharmacological treatments.
    • Existing antidepressants may have notable side-effects, necessitating the search for safer alternatives.

    Purpose of the Study:

    • To evaluate the efficacy and safety of nomifensine in treating depression.
    • To compare nomifensine's effects against placebo and other established antidepressants.

    Main Methods:

    • Conducted open and double-blind controlled studies globally.
    • Administered daily dosages of nomifensine ranging from 50-225 mg.
    • Treatment durations varied, extending up to 26 weeks.

    Main Results:

    Related Experiment Videos

    • Nomifensine exhibited considerable effectiveness in neurotic and reactive depressions.
    • The drug successfully counteracted inhibition and restored patient drive.
    • No significant cardiovascular or anticholinergic side-effects were observed.
    • Nomifensine did not potentiate the effects of alcohol.

    Conclusions:

    • Nomifensine is an effective treatment for specific types of depression.
    • Its favorable side-effect profile, including lack of cardiovascular and anticholinergic effects, makes it a potentially valuable therapeutic option.
    • The absence of alcohol potentiation further enhances its safety profile.